Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shiho Goda"'
Autor:
Kohei Yamamoto, Shinsuke Shiotsu, Misaki Sasakura, Shunya Tanaka, Shiho Goda, Taisuke Tsuji, Tatsuya Yuba, Chieko Takumi, Noriya Hiraoka
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 19, p2703-2707, 5p
Autor:
Yusuke Tachibana, Tadaaki Yamada, Taisuke Tsuji, Junji Murai, Kazuki Jinno, Shoki Matsumoto, Aosa Sasada, Shiho Goda, Ayaka Omura, Shinsuke Shiotsu, Tatsuya Yuba, Chieko Takumi, Noriya Hiraoka, Koichi Takayama
Recent studies have reported that coronavirus disease-2019 (COVID-19) vaccination can exacerbate asthma. Status asthmaticus sometimes induces takotsubo cardiomyopathy. We present a case of takotsubo cardiomyopathy triggered by asthma exacerbation aft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4604ed7e1b3dc105699ace3d7b92cc75
https://doi.org/10.22541/au.167454760.04808166/v1
https://doi.org/10.22541/au.167454760.04808166/v1
A case of non-small cell lung cancer with danazol-dependent aplastic anemia induced by pembrolizumab
Autor:
Shiho Goda, Yoshifumi Suga, Taisuke Tsuji, Ayaka Omura, Noriya Hiraoka, Shunya Tanaka, Hiroyuki Fujii, Tatsuya Yuba, Shinsuke Shiotsu, Yosuke Matsumoto, Aosa Matsuyama, Chieko Takumi
Publikováno v:
Current problems in cancer. 45(3)
Programmed cell death protein 1 immune checkpoint inhibitor is an effective treatment for non-small cell lung cancer. Although hematological immune-related adverse events induced by antiprogrammed-cell-death-protein-1 immunotherapy have been reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eee630e8b40449775df490626ade911
https://pubmed.ncbi.nlm.nih.gov/33293197
https://pubmed.ncbi.nlm.nih.gov/33293197
Autor:
Ayaka Omura, Shunya Tanaka, Taisuke Tsuji, Seiko Ono, Tatsuya Yuba, Chieko Takumi, Noriya Hiraoka, Shinsuke Shiotsu, Hiroyuki Fujii, Aosa Matsuyama, Yosuke Matsumoto, Yoshifumi Suga, Mio Sugitani, Shiho Goda
Publikováno v:
Current Problems in Cancer
We describe a case of coronavirus disease 2019 (COVID-19) in a patient with mixed cellularity classical Hodgkin lymphoma (cHL) undergoing brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) therapy. A 43-year-old man presented to o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3fb71315eb3cdceadc8d1b885f1e632
https://doi.org/10.1016/j.currproblcancer.2021.100739
https://doi.org/10.1016/j.currproblcancer.2021.100739
Autor:
Taisuke Tsuji, Yusuke Tachibana, Seiko Ono, Chieko Takumi, Noriya Hiraoka, Ryosuke Hamashima, Sayaka Uda, Shiho Goda, Aosa Matsuyama, Shinsuke Shiotsu, Hiroyuki Fujii, Ayaka Omura, Tatsuya Yuba
Publikováno v:
Infectious diseases (London, England). 52(1)
To the Editor,A recent report in this journal on the use of the T-SPOT.TB assay in a high TB burden country showed problem with short-term reproducibility [1]. Among patients undergoing at least tw...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6486ee98237f05eea3e90cd03db4f2f8
https://pubmed.ncbi.nlm.nih.gov/31512548
https://pubmed.ncbi.nlm.nih.gov/31512548
Autor:
Sayaka Uda, Seiko Ono, Tatsuya Yuba, Yusuke Tachibana, Shiho Goda, Aosa Matsuyama, Hiroyuki Fujii, Ayaka Omura, Ryosuke Hamashima, Taisuke Tsuji, Shinsuke Shiotsu, Chieko Takumi, Noriya Hiraoka
Publikováno v:
Infectious Diseases; Jan2020, Vol. 52 Issue 1, p58-60, 3p